The following should be monitored in persons with GAN:

Intellectual development/deterioration

Progression of the peripheral neuropathy, ataxia, spasticity, and cranial nerve dysfunction

The frequency of the monitoring should depend on disease progression; annual or more frequent evaluation is recommended.
